Evaluate the Efficacy of a Drug Candidate for Amyotrophic Lateral Sclerosis (ALS)

• Unité de recherche: INNOSUISSE
• Numéro de projet: 35796.1 IP-LS
• Titre du projet anglais: Evaluate the Efficacy of a Drug Candidate for Amyotrophic Lateral Sclerosis (ALS)

Description succincte (Allemand)

Evaluate the Efficacy of a Drug Candidate for Amyotrophic Lateral Sclerosis (ALS)

Description succincte (Anglais)

Evaluate the Efficacy of a Drug Candidate for Amyotrophic Lateral Sclerosis (ALS)

Résumé des résultats (Abstract) (Allemand)

SBC003 is a synthetic natural neuroprotective agent showing promising effects in Amyotrophic Lateral Sclerosis (ALS) models. The objective of this project is to further evaluate the efficacy and mode of action of SBC003 in both in vivo and in vitro ALS disease models.